Previous Article | Next Article 
Journal of Clinical Microbiology, March 2000, p. 1063-1065, Vol. 38, No. 3
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of the Oricult-N Dipslide for Laboratory
Diagnosis of Vaginal Candidiasis
Petteri
Carlson,1,*
Malcolm
Richardson,2 and
Jorma
Paavonen3
Division of Bacteriology, HUCH
Diagnostics,1 and Department of
Obstetrics and Gynecology,3 Helsinki
University Central Hospital, and Department of Bacteriology and
Immunology, Haartman Institute, University of
Helsinki,2 Helsinki, Finland
Received 17 August 1999/Returned for modification 27 September
1999/Accepted 1 December 1999
 |
ABSTRACT |
The Oricult-N semiquantitative dipslide (Orion Diagnostica, Espoo,
Finland) was evaluated for the laboratory diagnosis of vaginal
candidiasis. It was compared with broth culture (Vagicult; Orion
Diagnostica). Oricult-N was positive for 14.5% of 124 symptomatic patients and 12% of 50 asymptomatic controls. The results for broth
cultures were 17 and 22%, respectively. Thus, the test group and the
control group did not differ significantly by either method. High
vaginal yeast counts (
105 CFU/ml) were detected by
Oricult-N in 7% of patients and in 0% of controls, but both groups
harbored low numbers of yeasts. An accurate quantitative cutoff point
separating a level of yeast associated with infection from vaginal
yeast carriage could not be defined in the study. Nevertheless, the
easy semiquantitation allowed by the Oricult-N method could be helpful
because, especially in low-count carriers of Candida, other
potential causes of vaginal symptoms should be considered. The
Oricult-N method was technically simple and could be applied in primary
health care. Further studies are required, however, before Oricult-N
can be recommended as a routine diagnostic tool.
 |
INTRODUCTION |
Vaginal candidiasis is one of the
most common infections seen in general practice. Forty to 75% of
sexually active women have experienced symptomatic vaginal candidiasis
(3). Symptoms of vaginal candidiasis are itching, burning,
soreness, abnormal vaginal discharge, and dyspareunia. Signs include
vaginal and vulvar erythema and edema (16). The most common
causative agent is Candida albicans, but the proportion of
other species, especially Candida glabrata, is increasing
(17, 19).
The vaginal Candida carriage rate for asymptomatic
nonpregnant women is around 20% (10). In pregnancy, the
rate tends to be higher. There is little definitive quantitative data
on the amount of vaginal Candida in apparently healthy
carriers. The numbers of yeasts are usually low in asymptomatic women,
but thousandfold differences in the quantities of yeasts recovered from
these asymptomatic women may exist (9, 12). Why carriers of
Candida develop an episode of symptomatic disease is at
present poorly understood, but it is assumed that both host- and
pathogen-related factors are involved.
The clinical diagnosis of vaginal candidiasis is unreliable (6,
11, 17), and laboratory confirmation is needed. Microscopy, yeast
cultures, and latex agglutination tests have been used (5). Wet mounts prepared in saline or 10% KOH, as well as Gram-stained smears, can be microscopically examined. The sensitivity of microscopy compared to culture is about 30 to 45% (5, 18).
Sabouraud dextrose agar plates and, more infrequently, broth media or
dipslides have been used in vaginal yeast cultures. Substantial
controversy exists about the interpretation of a positive culture
result. Traditionally, any growth of Candida has been considered a pathological finding. More recently, however, it has been
shown that symptomatic candidiasis is usually associated with higher
numbers of vaginal yeasts than those found in asymptomatic carriers
(6, 8, 12). Unfortunately, conventional mycological laboratory techniques for yeast quantitation involve serial dilutions (8), and dipslides or broth media do not allow for
quantitation (4, 13, 14, 20).
The Oricult-N semiquantitative dipslide method (Orion Diagnostica,
Espoo, Finland) was developed for the enumeration of yeasts in clinical
samples. In particular, it has been applied to the quantitation of
Candida species in the oral cavity (1). In the
present study, we evaluated the Oricult-N method in the laboratory diagnosis of Candida vaginitis. It was compared with
microscopy and broth culture. Both symptomatic women and a group of
healthy volunteers were studied.
 |
MATERIALS AND METHODS |
Patients.
The study population consisted of 124 consecutive
nonpregnant women attending the gynecological outpatient clinic of the
University Central Hospital, Helsinki, Finland, for suspected
vaginitis. The mean age of the patients was 37 years, with a range of
19 to 81 years. Women who had received any antibacterial or antifungal agents during the preceeding 14 days were excluded from the study. The
patients had had an average of 0.8 deliveries (range, 0 to 6), 18 (15%) used oral contraceptives, and 2 (2%) had an intrauterine device. Gynecological speculum examination was performed by one of us
(J.P.). Symptoms of itching and soreness, signs of vulvovaginitis, mucosal edema, and the presence and nature of vaginal discharge were
noted. Fifty gynecologically asymptomatic female health care professionals (mean age, 40 years; range, 19 to 58 years) formed the
control group.
Specimen collection and laboratory techniques.
Two swabs
were taken high in the vagina of each patient and control subject. A
wet smear in physiological saline was immediately prepared from the
first swab. The smears were examined by microscopy for the presence of
characteristic yeast and hyphal forms of Candida species.
The second swab was first rubbed thoroughly on the surface of an
Oricult-N dipslide and then immersed into a liquid medium (Vagicult;
Orion Diagnostica). The Oricult-N slide consists of Nickerson's medium
containing chloramphenicol and gentamicin to control bacterial
overgrowth. Candida species grow on it as characteristic brown-pigmented, smooth colonies (1, 15). The slides were incubated at 37°C for 2 days before examination, as recommended by
the manufacturer. The numbers of colonies per square centimeter of agar
surface were then counted. The number of yeasts per milliliter (range,
<103 to 106 CFU/ml) in the original vaginal
secretion was estimated by comparing the colony densities to color
charts provided by the manufacturer. The Vagicult tubes were incubated
for 2 days at 37°C before microscopic examination for yeasts.
The data were analyzed using the two-tailed Fisher's exact test.
 |
RESULTS |
The wet mount microscopy and qualitative Vagicult and Oricult-N
culture results are given in Table 1. The
microscopy was positive for yeast for 14 of the 124 patients (11%).
However, only eight (57%) of these could be verified by culture. Two
of 50 controls (4%) had a positive result in microscopy, and both were
also culture positive. The results of both culture methods were easy to
interpret. Bacterial overgrowth did not interfere with reading of
Oricult-N slides. Eighteen of the patients (14.5%) and six controls
(12%) had positive Oricult-N cultures, while the Vagicult cultures
were positive in 21 (17%) versus 11 (22%) subjects, respectively. The
patient and control groups did not differ statistically by either of
the culture methods. The sensitivity, specificity, and positive and
negative predictive values of the qualitative Oricult-N culture
compared to the Vagicult broth culture in the patient group were 86, 100, 100, and 100%, respectively. The quantitative results given by
the Oricult-N method are given in Table
2. Nine of the patients (7%) but none of
the controls had high counts of yeasts (
105 CFU/ml) in
their vaginas, while there was low-grade carriage of yeasts
(
104 CFU/ml) in both patients (9 of 124 [7%]) and
controls (6 of 50 [12%]). When groups of women with either no yeasts
or only low numbers of yeasts (
104 CFU/ml) in their
vaginas were combined and then compared to subjects with high vaginal
yeast counts (
105 CFU/ml) (see Table 2 for details),
patients and controls differed, but not statistically significantly
(P = 0.089). As can be seen in Fig.
1, the distribution of yeast counts was
bimodal in the culture-positive patient group but unimodal in the
corresponding control group.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Proportions of vaginal swabs that were microscopy and
culture positive in vaginitis patients and control subjects
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Distribution of Oricult-N results for culture-positive
patients (n = 18) ( ) and controls
(n = 6) ( ).
|
|
The diagnoses of the 103 symptomatic women who remained culture
negative included trichomoniasis in one patient, bacterial vaginosis in
one patient, condylomatous vaginitis in one patient, and desquamative
inflammatory vaginitis in five patients. In addition, noninfectious
conditions were diagnosed in three cases (lichen sclerosus in two cases
and lichen planus in one case).
 |
DISCUSSION |
Candida carriage in the vagina has often been studied
with both healthy women and those suffering from vaginitis. However, attention has rarely been paid to the quantities of yeasts in these
groups. The present study has shown that it is possible to obtain
semiquantitative estimates of vaginal yeast amounts using a simple and
practical dipslide method. The technique could be particularly
applicable to primary health care, because special mycological
laboratory facilities are not required. The Oricult-N slide can be
referred to a reference laboratory for further testing if necessary.
In the present study it was clearly shown that qualitative yeast
cultures do not separate patient and control groups. As has been shown
previously by others, broth culture methods like Vagicult do not
discriminate between patients with disease and symptom-free carriers
(14). Microscopy may be better in this respect, because its
sensitivity is probably lower than that of culture. The fact that 6 of
14 patients with positive microscopic examinations were negative by
culture may be due to false-positive microscopy results or because not
all yeast cells seen were viable. Patients harboring vaginal yeasts can
be divided into two groups, i.e., those with either low or high yeast
counts. Carriers with low counts may well represent women having
vaginal symptoms caused by etiologic factors other than
Candida. We emphasize that all vaginitis patients should be
carefully evaluated for other etiologies besides Candida. When Candida vaginitis is suspected, a wet mount for direct
microscopy is usually first prepared. If the result is negative for
yeasts, a swab for a qualitative yeast culture is sometimes taken.
However, the indiscriminate use and interpretation of qualitative
Candida cultures may lead to overdiagnosis and excessive
antifungal treatment.
Most of the earlier studies have shown some degree of correlation
between the numbers of vaginal yeasts and symptoms and signs of
vaginitis (6, 8, 11, 12), although two studies gave opposite
results (2, 21). The control groups in earlier studies have
consisted either exclusively or at least in part of women suspected to
have a sexually transmitted disease or some other gynecological
disorder (2, 6, 8, 11, 12, 21). According to Odds
(10), a higher proportion of these females than healthy volunteers tend to carry vaginal yeasts. For this reason, we used healthy volunteers as controls.
The most accurate sampling technique for suspected vaginitis is a
vaginal washing (8). Odds and coworkers (9, 12) and Hopwood et al. (8) have shown, however, that vaginal
swabs are a sufficiently sensitive and reproducible substitute. The methods of quantitation used in the past have usually been quite imprecise. The range of quantitation of the Oricult-N method used in
the present study extended from <103 to 106
CFU of yeasts per ml in the original sample, a range broader than in
most previous studies. Simple swabbing of a Sabouraud dextrose plate
allows counting of colonies from 1 to 100. According to Odds
(9), these colony counts correspond to a range of
103 to at most 105 CFU/ml in the original
vaginal secretion. In this study, we somewhat arbitrarily set a cutoff
point of 105 CFU/ml as a pathological vaginal yeast count.
In two previous studies (6, 9), 10 colonies growing on a
swabbed culture plate has been proposed as a limit between a
pathological and a physiological amount of Candida in the
vagina. This corresponds to about 104 CFU/ml in the
original vaginal fluid. Hopwood et al. (8) proposed a
broader range, i.e., one between 103 and 105
CFU/ml. As can be seen in Fig. 1, both patients and healthy controls had yeast contents of 104 CFU/ml in their vaginas; this may
represent an intermediate zone between the groups.
An accurate cutoff point between a physiological and a pathological
vaginal yeast content cannot yet be defined based on the present or
previous studies. More patients need to be studied and more clinical
experience needs to be gained before any firmer conclusions can be
drawn. In selected cases, women may become sensitized to
Candida (7) and then even small amounts of yeasts may elicit intense symptoms.
The Oricult-N method was easy to use and easy to interpret. It provided
a semiquantitative estimate of the vaginal yeast count, which could be
useful to clinicians in evaluating patients with suspected vaginal
candidiasis. Further studies are required, however, before the product
can be recommended as a routine diagnostic tool.
 |
ACKNOWLEDGMENT |
This work was supported in part by Pfizer, Finland.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Bacteriology, HUCH Diagnostics, Helsinki University Central Hospital,
P.O. Box 402, FIN-00029 HYKS, Finland. Phone: 358-9-19126250. Fax: 358-9-19126244. E-mail: petteri.carlson{at}huch.fi.
 |
REFERENCES |
| 1.
|
Axéll, T.,
T. Simonsson,
D. Birkhed,
J. Rosenborg, and S. Edwardsson.
1985.
Evaluation of a simplified diagnostic aid (Oricult-N) for detection of oral candidoses.
Scand. J. Dent. Res.
93:52-55[Medline].
|
| 2.
|
Bro, F.
1989.
The diagnosis of Candida vaginitis in general practice.
Scand. J. Prim. Health Care
7:19-22[Medline].
|
| 3.
|
Eckert, L. O.,
S. E. Hawes,
C. E. Stevens,
L. A. Koutsy,
D. A. Eschenbach, and K. K. Holmes.
1998.
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm.
Obstet. Gynecol.
92:757-765[CrossRef][Medline].
|
| 4.
|
Erdman, Y. J.,
J. M. Holton, and A. Baker.
1984.
Growth of Candida species in liquid culture medium for Trichomonas vaginalis.
Br. J. Vener. Dis.
60:39-41[Medline].
|
| 5.
|
Evans, E. G. V.
1990.
Diagnostic laboratory techniques in vaginal candidosis.
Br. J. Clin. Pract. Suppl.
71:70-72[Medline].
|
| 6.
|
Evans, E. G. V.,
C. J. N. Lacey, and J. A. Carney.
1986.
Criteria for the diagnosis of vaginal candidosis: evaluation of a new latex agglutination test.
Eur. J. Obstet. Gynecol. Reprod. Biol.
22:365-371[CrossRef][Medline].
|
| 7.
|
Fidel, P. L., and J. D. Sobel.
1996.
Immunopathogenesis of recurrent vulvovaginal candidiasis.
Clin. Microbiol. Rev.
9:335-348[Abstract].
|
| 8.
|
Hopwood, V.,
T. Crowley,
C. T. Horrocks,
J. D. Milne,
P. K. Taylor, and D. W. Warnock.
1988.
Vaginal candidosis: relation between yeast counts and symptoms and clinical signs in non-pregnant women.
Genitourin. Med.
64:331-334[Medline].
|
| 9.
|
Odds, F. C.
1982.
Genital candidosis.
Clin. Exp. Dermatol.
7:345-354[Medline].
|
| 10.
|
Odds, F. C.
1988.
Candida and candidosis, 2nd ed., p. 68-92.
Baillière Tindall, London, England.
|
| 11.
|
Odds, F. C.,
C. E. Webster,
P. Mayuranathan, and P. D. Simmons.
1988.
Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis.
J. Med. Vet. Mycol.
26:277-283[Medline].
|
| 12.
|
Odds, F. C.,
C. E. Webster,
V. C. Riley, and P. G. Fisk.
1987.
Epidemiology of vaginal Candida infection: significance of numbers of vaginal yeasts and their biotypes.
Eur. J. Obstet. Gynecol. Reprod. Biol.
25:53-66[CrossRef][Medline].
|
| 13.
|
Pattman, R. S.,
M. S. Sprott, and T. R. Moss.
1981.
Evaluation of a culture slide in the diagnosis of vaginal candidosis.
Br. J. Vener. Dis.
57:69.
|
| 14.
|
Räisänen, S.,
S. Eskelinen,
M. Merilä, and M. Kaartinen.
1982.
Diagnosis of candidal colpitis using a semiliquid culture medium.
Ann. Chir. Gynaecol.
71:340-343[Medline].
|
| 15.
|
Roser, H.
1970.
Bakteriologische diagnostik von Candida-erkrankungen auf Nickersons Medium.
Med. Welt
17:792-793[Medline].
|
| 16.
|
Sobel, J. D.
1990.
Vaginal infections in adult women.
Sex. Transm. Dis.
74:1573-1601.
|
| 17.
|
Sobel, J. D.
1997.
Current concepts: vaginitis.
N. Engl. J. Med.
337:1896-1903[Free Full Text].
|
| 18.
|
Sobel, J. D.,
S. Faro,
R. W. Force,
B. Foxman,
W. J. Ledger,
P. R. Nyirjesy,
B. D. Reed, and P. R. Summers.
1998.
Vulvoginal candidiasis: epidemiological, diagnostic and therapeutic considerations.
Am. J. Obstet. Gynecol.
178:203-211[CrossRef][Medline].
|
| 19.
|
Spinillo, A.,
E. Capuzzo,
T. O. Egbe,
F. Baltaro,
S. Nicola, and G. Piazzi.
1995.
Torulopsis glabrata vaginitis.
Obstet. Gynecol.
85:993-998[CrossRef][Medline].
|
| 20.
|
Weissberg, S. M.
1978.
Evaluation of a dipstick for Candida.
Obstet. Gynecol.
52:506-509[Medline].
|
| 21.
|
Zdolsek, B.,
D. Hellberg,
G. Fróman,
S. Nilsson, and P. E. Mårdh.
1995.
Culture and wet smear microscopy in the diagnosis of low-symptomatic vulvovaginal candidosis.
Eur. J. Obstet. Gynecol. Reprod. Biol.
58:47-51[CrossRef][Medline].
|
Journal of Clinical Microbiology, March 2000, p. 1063-1065, Vol. 38, No. 3
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Anderson, M. R., Klink, K., Cohrssen, A.
(2004). Evaluation of Vaginal Complaints. JAMA
291: 1368-1379
[Abstract]
[Full Text]